You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Fluidigm this week launched its EP1 system for high-throughput SNP genotyping and digital PCR.
Using Fluidigm’s dynamic arrays, the system can provide up to 9,216 data points per IFC chip with results in just four hours. The system includes the firm’s IFC Controller, Stand Alone Thermal Cycler and End Point Reader, and can provides over 27,000 genotypes a day.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.
The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.
Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.
In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.
In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.